Neuroendocrine tumours (NETs) are derived from neuroendocrine cells and can occur in the gastrointestinal system and pancreas, among other organs. The vague symptoms of atheromatous epithelial cells (NETs) might be a significant problem due to their restricted range of available remedies and potential delay in identification. Established methods of diagnosis and increased healthcare professional awareness of NET features are critical for better patient outcomes.